GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Asset Impairment Charge

ASKA Pharmaceutical Holdings Co (TSE:4886) Asset Impairment Charge : 円0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is ASKA Pharmaceutical Holdings Co Asset Impairment Charge?

ASKA Pharmaceutical Holdings Co's Asset Impairment Charge for the three months ended in Sep. 2024 was 円0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 was 円0 Mil.

ASKA Pharmaceutical Holdings Co Asset Impairment Charge Historical Data

The historical data trend for ASKA Pharmaceutical Holdings Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASKA Pharmaceutical Holdings Co Asset Impairment Charge Chart

ASKA Pharmaceutical Holdings Co Annual Data
Trend Mar22 Mar23 Mar24
Asset Impairment Charge
- - -

ASKA Pharmaceutical Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ASKA Pharmaceutical Holdings Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

ASKA Pharmaceutical Holdings Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of ASKA Pharmaceutical Holdings Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

ASKA Pharmaceutical Holdings Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Asset Impairment Charge
Comparable Companies
TSE:4569 TSE:4554 TSE:4577 TSE:4595 TSE:4559 TSE:9273 TSE:2929 TSE:4534 TSE:4538 TSE:4574 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532
Website
https://www.aska-pharma-hd.co.jp
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.

ASKA Pharmaceutical Holdings Co Headlines

No Headlines